| 1. |
|
|
| 2. |
|
|
| 3. |
- Buchan, K. L., et al.
(författare)
-
Comparing the drift of Laurentia and baltica in the Proterozoic : the importance of key palaeomagnetic poles
- 2000
-
Ingår i: Tectonophysics. - 0040-1951 .- 1879-3266. ; 319:3, s. 167-198
-
Tidskriftsartikel (refereegranskat)abstract
- Key palaeomagnetic poles are defined as those which pass basic reliability criteria and are precisely and accurately dated. They allow a more rigorous analysis of Precambrian continental drift and continental reconstructions than the traditional apparent polar wander path (APWP) approach using mostly non-key poles. Between ca. 2.45 and 2.00 Ga in the early Palaeoproterozoic, key poles define the drift of the Archaean Superior craton of Laurentia, yielding a result that is quite unlike the drift interpreted in earlier studies using the APWP method. There are no early Palaeoproterozoic key poles for the other Archaean cratons that amalgamated to form Laurentia and Baltica prior to 1.8 Ga, so that a rigorous test of early Palaeoproterozoic reconstruction models is not possible. Key poles from Laurentia between ca. 1.46 and 1.267 Ga and Baltica between 1.63 and 1.265 Ga help to define, in a preliminary fashion, the early Mesoproterozoic drift of the two shields. The key pole age match at ca. 1.265 Ga is consistent with Baltica located adjacent to eastern Greenland, and geological considerations suggest that the most reasonable fit aligns the Labradorian belt of Laurentia with the Gothian belt of Baltica. Although there is limited support from non-key poles and key poles that are not matched in age for such a fit as early as ca. 1.8 Ga, no rigorous assessment will be possible until a match in key pole ages is achieved. In the late Mesoproterozoic to Neoproterozoic, Laurentia's drift is reasonably well documented by seven key poles between 1.235 and 0.73 Ga. There are no key poles in this period from Baltica, however, so that a ≈90° clockwise rotation of Baltica relative to Laurentia between 1.265 and 1.0 Ga, widely used in the literature, cannot be confirmed.
|
|
| 4. |
- Abrahamsen, R., et al.
(författare)
-
Non-response in a cross-sectional study of respiratory health in Norway
- 2016
-
Ingår i: Bmj Open. - : BMJ. - 2044-6055. ; 6:1
-
Tidskriftsartikel (refereegranskat)abstract
- Objectives: Declining participation in epidemiological studies has been reported in recent decades and may lead to biased prevalence estimates and selection bias. The aim of the study was to identify possible causes and effects of non-response in a population-based study of respiratory health in Norway. Design: The Telemark study is a longitudinal study that began with a cross-sectional survey in 2013. Setting: In 2013, a random sample of 50 000 inhabitants aged 16-50 years, living in Telemark county, received a validated postal questionnaire. The response rate was 33%. In this study, a random sample of 700 non-responders was contacted first by telephone and then by mail. Outcome measures: Response rates, prevalence and OR of asthma and respiratory symptoms based on exposure to vapours, gas, dust or fumes (VGDF) and smoking. Causes of non-response. Results: A total of 260 non-responders (37%) participated. Non-response was associated with younger age, male sex, living in a rural area and past smoking. The prevalence was similar for responders and non-responders for physician-diagnosed asthma and several respiratory symptoms. The prevalence of chronic cough and use of asthma medication was overestimated in the Telemark study, and adjusted prevalence estimates were 17.4% and 5%, respectively. Current smoking was identified as a risk factor for respiratory symptoms among responders and non-responders, while occupational VGDF exposure was a risk factor only among responders. The Breslow-Day test detected heterogeneity between productive cough and occupational VGDF exposure among responders. Conclusions: The Telemark study provided valid estimates for physician-diagnosed asthma and several respiratory symptoms, while it was necessary to adjust prevalence estimates for chronic cough and use of asthma medication. Reminder letters had little effect on risk factor associations. Selection bias should be considered in future investigations of the relationship between respiratory outcomes and exposures.
|
|
| 5. |
- Ali, M. M., et al.
(författare)
-
Addition of Anti-thymocyte Globulin in Allogeneic Stem Cell Transplantation With Peripheral Stem Cells From Matched Unrelated Donors Improves Graft-Versus-Host Disease and Relapse Free Survival
- 2021
-
Ingår i: Clinical Lymphoma, Myeloma & Leukemia. - : Elsevier. - 2152-2650 .- 2152-2669. ; 21:9, s. 598-605
-
Tidskriftsartikel (refereegranskat)abstract
- In 2014 we introduced anti-thymocyte globulin (ATG) to the graft-versus-host disease (GvHD) prophylaxis regimen in allogeneic stem cell transplantation (Allo-HSCT) with peripheral stem cells (PBSC) from matched unrelated donors (MUD). We analysed the outcomes of 415 patients who went through MUD alto-HSCT and received PBSC with or without ATG. We report dramatic reduction of the incidence of chronic GvHD and our study illustrates the benefit of ATG in addition to standard GvHD prophylaxis. Anti-thymocyte globulin (ATG) is commonly used to prevent graft-versus-host disease (GvHD) after allogeneic hematopoietic stem cell transplantation (allo-HSCT). To evaluate the impact of ATG as part of the GvHD prophylaxis in our institution, we report the outcome of 415 patients with matched unrelated donors (MUD) transplanted for hemato-logical malignancies with or without ATG from 2005 to 2019 at Oslo University Hospital, Norway. The following groups were compared: (1) 154 patients transplanted with peripheral blood stem cells (PBSC) without ATG 2005-2014. (2) 137 patients transplanted with bone marrow stem cells (BMSC) 2005-2019. (3) 124 patients transplanted with PBSC and ATG (PBSC + ATG) 2014-2019. Three years survival was similar in the groups, 61% following allografting with PBSC, 54% with BMSC, and 59% with PBSC + ATG. Acute GvHD grade III-IV was 14%, 14%, and 7%; chronic GvHD was 81%, 32, and 26%; and extensive cGvHD 44%, 15%, and 6% in the corresponding groups. Both acute and chronic GvHD were significantly reduced in the PBSC + ATG-versus the PBSC group (p < 0.05 and p < 0.001 respectively).Transplant-related mortality (TRM) was 33%, 25%, and 17% (p = 0.18). Graft versus host disease and relapse free survival (GRFS) at 3 years was 43 %, 43%, and 64% in the groups. Adding ATG to the GvHD prophylaxis regimen of MUD allo-HSCT with PBSC resulted in a substantial reduction of both acute and chronic GvHD without compromising the disease control, reflected in a superior 3 years GRFS.
|
|
| 6. |
- Bergqvist, Joel, et al.
(författare)
-
Chronic rhinosinusitis associated with chronic bronchitis in a five-year follow-up: the Telemark study
- 2022
-
Ingår i: Bmc Pulmonary Medicine. - : Springer Science and Business Media LLC. - 1471-2466. ; 22:1
-
Tidskriftsartikel (refereegranskat)abstract
- Background Chronic rhinosinusitis (CRS) is associated with generalised airway inflammation. Few studies have addressed the relationship between CRS and chronic bronchitis (CB). Methods This prospective study over a five-year period aims to investigate the risk of developing CB in subjects reporting CRS at the beginning of the study. A random sample of 7393 adult subjects from Telemark County, Norway, answered a comprehensive respiratory questionnaire in 2013 and then 5 years later in 2018. Subjects reporting CB in 2013 were excluded from the analyses. New cases of CB in 2018 were analysed in relation to having CRS in 2013 or not. Results The prevalence of new-onset CB in 2018 in the group that reported CRS in 2013 was 11.8%. There was a significant increase in the odds of having CB in 2018 in subjects who reported CRS in 2013 (OR 3.8, 95% CI 2.65-5.40), adjusted for age, sex, BMI, smoking and asthma. Conclusion In this large population sample, CRS was associated with increased odds of developing CB during a five-year follow-up. Physicians should be aware of chronic bronchitis in patients with CRS.
|
|
| 7. |
- Enqvist, M., et al.
(författare)
-
Coordinated expression of DNAM-1 and LFA-1 in educated NK cells
- 2015
-
Ingår i: Journal of Immunology. - : The American Association of Immunologists. - 0022-1767 .- 1550-6606. ; 194:9, s. 4518-4527
-
Tidskriftsartikel (refereegranskat)abstract
- The functional capacity of NK cells is dynamically tuned by integrated signals from inhibitory and activating cell surface receptors in a process termed NK cell education. However, the understanding of the cellular and molecular mechanisms behind this functional tuning is limited. In this study, we show that the expression of the adhesion molecule and activation receptor DNAX accessory molecule 1 (DNAM-1) correlates with the quantity and quality of the inhibitory input by HLA class I-specific killer cell Ig-like receptors and CD94/NKG2A as well as with the magnitude of functional responses. Upon target cell recognition, the conformational state of LFA-1 changed in educated NK cells, associated with rapid colocalization of both active LFA-1 and DNAM-1 at the immune synapse. Thus, the coordinated expression of LFA-1 and DNAM-1 is a central component of NK cell education and provides a potential mechanism for controlling cytotoxicity by functionally mature NK cells.
|
|
| 8. |
|
|
| 9. |
- Ferrari, S. L., et al.
(författare)
-
Diagnosis and management of bone fragility in diabetes : an emerging challenge
- 2018
-
Ingår i: Osteoporosis International. - : Springer Science and Business Media LLC. - 0937-941X .- 1433-2965. ; 29:12, s. 2585-2596
-
Tidskriftsartikel (refereegranskat)abstract
- Fragility fractures are increasingly recognized as a complication of both type 1 and type 2 diabetes, with fracture risk that increases with disease duration and poor glycemic control. Yet the identification and management of fracture risk in these patients remains challenging. This review explores the clinical characteristics of bone fragility in adults with diabetes and highlights recent studies that have evaluated bone mineral density (BMD), bone microstructure and material properties, biochemical markers, and fracture prediction algorithms (i.e., FRAX) in these patients. It further reviews the impact of diabetes drugs on bone as well as the efficacy of osteoporosis treatments in this population. We finally propose an algorithm for the identification and management of diabetic patients at increased fracture risk.
|
|
| 10. |
|
|
